What is Quantum Enterprises?
Established in 1997, Quantum Enterprises, Inc. provides specialized consulting services for R&D in the pharmaceutical and biotechnology industries. Their expertise spans critical areas such as Content Management, meta-data and taxonomy management, Biostatistics/SAS training and analysis, Clinical research, Drug marketing studies, Regulatory submissions and publishing, CMC, Labeling, Clinical trial management, and SAS programming support. The company leverages deep understanding of the pharmaceutical business environment, including its local and global integrated functioning, and emphasizes the importance of business processes and technology. QE's core team comprises senior, Ph. D. level professionals with extensive experience in NDA/PMA submissions and FDA interactions related to statistical issues. Their client roster includes major pharmaceutical corporations such as Bristol-Myers Squibb, Sanofi-Aventis, Eli Lilly, and Merck, alongside mid-sized pharmaceutical companies and CROs. Quantum Enterprises focuses on aligning business strategies with IT vision to address the challenges of a competitive global market.
How much funding has Quantum Enterprises raised?
Quantum Enterprises has raised a total of $15K across 1 funding round:
Debt
$15K
Debt (2021): $15K with participation from PPP
What's next for Quantum Enterprises?
Operating at a Series A/B growth stage, Quantum Enterprises' recent infusion of moderate growth capital signals a strategic push towards scaling its operations and potentially expanding its service portfolio. The company's established track record with Fortune 500 pharmaceutical clients suggests a strong foundation for future development. Future initiatives will likely focus on deepening its consulting capabilities in biostatistics, clinical trial management, and regulatory affairs, while continuing to integrate advanced IT solutions to meet the evolving needs of the life sciences sector. This strategic investment is expected to fuel further innovation and solidify its position as a key R&D consulting partner.
See full Quantum Enterprises company page
